Retraction
The complex PrP(c)-Fyn couples human oligomeric Aβ with pathological tau changes in Alzheimer's disease
Paper Information
Record ID:
64366
Author(s):
Journal:
Publication Date:
November 21, 2012
Retraction Date:
March 12, 2025
(<1 year years ago)
Subjects:
Institutions:
- Departments of Neuroscience, N. Bud Grossman Center for Memory Research and Care, Institute for Translational Neuroscience, University of Minnesota, Minneapolis, Minnesota 55414
- N. Bud Grossman Center for Memory Research and Care, Institute for Translational Neuroscience, University of Minnesota, Minneapolis, Minnesota 55414
- Institute for Translational Neuroscience, University of Minnesota, Minneapolis, Minnesota 55414
- Institute of Neuropathology, University Hospital of Zurich, 8091 Zurich, Switzerland
- Amyloid Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Department of Molecular Medicine, University of Pavia and Istituto Universitario di Studi Superiori di Pavia, I-27100 Pavia, Italy
- Universitario di Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois 60612
Countries:
Article Type:
Publisher:
Society for Neuroscience
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1523/JNEUROSCI.0301-25.2025Additional Notes:
see also: https://pubpeer.com/publications/841806329CBD4CD2593E83C5E369EA
Citations (273)
273
Total Citations2
Post-Retraction(0.7%)
271
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
63
Days since retraction (latest)
From Molecular Circuit Dysfunction to Disease
Chris G. Dulla, Douglas A. Coulter, Jokūbas Žiburkus
The Neuroscientist
Open Access
Published: May 2015
28 citations
28 citations
3598 days before retraction
Animal models for prion-like diseases
Natalia Fernández‐Borges, Hasier Eraña, Vanesa Venegas et al. (6 authors)
Virus Research
Published: Apr 2015
12 citations
12 citations
3614 days before retraction
Paper citing The complex PrP(c)-Fyn couples human oligomeric Aβ...
Unknown Authors
Unknown Journal
Published: Apr 2015
3620 days before retraction
The prion protein regulates beta-amyloid-mediated self-renewal of neural stem cells in vitro
Steven Collins, Carolin Tumpach, Qiao‐Xin Li et al. (9 authors)
Stem Cell Research & Therapy
Open Access
Published: Apr 2015
13 citations
13 citations
3624 days before retraction
The Essential Role of Soluble Aβ Oligomers in Alzheimer’s Disease
Zixuan Wang, Lan Tan, Jinyuan Liu et al. (4 authors)
Molecular Neurobiology
Published: Apr 2015
88 citations
88 citations
3632 days before retraction
A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer’s disease
Haakon B. Nygaard, Allison F. Wagner, Garrett S Bowen et al. (15 authors)
Alzheimer s Research & Therapy
Open Access
Published: Mar 2015
149 citations
149 citations
3638 days before retraction
Tau Immunotherapy Modulates Both Pathological Tau and Upstream Amyloid Pathology in an Alzheimer's Disease Mouse Model
Diana L. Castillo‐Carranza, Marcos J. Guerrero-Muñoz, Urmi Sengupta et al. (7 authors)
Journal of Neuroscience
Open Access
Published: Mar 2015
135 citations
135 citations
3640 days before retraction
Paper citing The complex PrP(c)-Fyn couples human oligomeric Aβ...
Unknown Authors
Unknown Journal
Published: Mar 2015
3647 days before retraction
<scp>F</scp>yn inhibition rescues established memory and synapse loss in <scp>A</scp>lzheimer mice
A Kaufman, Santiago V. Salazar, Laura T. Haas et al. (11 authors)
Annals of Neurology
Open Access
Published: Feb 2015
296 citations
296 citations
3669 days before retraction
Fragile X mental retardation protein: from autism to neurodegenerative disease
Hansen Wang
Frontiers in Cellular Neuroscience
Open Access
Published: Feb 2015
22 citations
22 citations
3681 days before retraction
Subcellular distribution of the prion protein in sickness and in health
Susan F. Godsave, Peter J. Peters, Holger Wille
Virus Research
Open Access
Published: Feb 2015
22 citations
22 citations
3681 days before retraction
The sheddase ADAM10 is a potent modulator of prion disease
Hermann C. Altmeppen, Johannes Prox, Susanne Krasemann et al. (14 authors)
eLife
Open Access
Published: Feb 2015
83 citations
83 citations
3688 days before retraction
Prion protein (PrP) gene-knockout cell lines: insight into functions of the PrP
Akikazu Sakudo, Takashi Onodera
Frontiers in Cell and Developmental Biology
Open Access
Published: Jan 2015
10 citations
10 citations
3709 days before retraction
Pseudophosphorylation of Tau at distinct epitopes or the presence of the P301L mutation targets the microtubule-associated protein Tau to dendritic spines
Di Xia, Chuanzhou Li, Jürgen Götz
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Open Access
Published: Jan 2015
87 citations
87 citations
3721 days before retraction
Functional implications of tau-fyn interactions in Alzheimer's disease
Hay Wun Dawn Lau
Unknown Journal
Published: Jan 2015
3723 days before retraction
Drug Repositioning Approaches for the Discovery of New Therapeutics for Alzheimer's Disease
Taewan Kim
Neurotherapeutics
Open Access
Published: Dec 2014
78 citations
78 citations
3725 days before retraction
Toxic oligomer species of amyloid-β in Alzheimer's disease, a timing issue
Sylvain Lesné
Schweizerische medizinische Wochenschrift
Open Access
Published: Nov 2014
23 citations
23 citations
3779 days before retraction
Single‐Molecule Imaging Reveals that Small Amyloid‐β<sub>1–42</sub> Oligomers Interact with the Cellular Prion Protein (PrP<sup>C</sup>)
Kristina A. Ganzinger, Priyanka Narayan, Seema Qamar et al. (10 authors)
ChemBioChem
Open Access
Published: Oct 2014
45 citations
45 citations
3809 days before retraction
AlphaScreen HTS and Live-Cell Bioluminescence Resonance Energy Transfer (BRET) Assays for Identification of Tau–Fyn SH3 Interaction Inhibitors for Alzheimer Disease
J. Nicholas Cochran, Pauleatha Diggs, N. Miranda Nebane et al. (9 authors)
SLAS DISCOVERY
Open Access
Published: Aug 2014
25 citations
25 citations
3851 days before retraction
Therapeutic Molecules and Endogenous Ligands Regulate the Interaction between Brain Cellular Prion Protein (PrPC) and Metabotropic Glutamate Receptor 5 (mGluR5)
Laura T. Haas, Mikhail A. Kostylev, Stephen M. Strittmatter
Journal of Biological Chemistry
Open Access
Published: Aug 2014
78 citations
78 citations
3854 days before retraction
Lipid rafts: linking prion protein to zinc transport and amyloid-β toxicity in Alzheimer's disease
Nicole T. Watt, Heledd Jarosz-Griffiths, Nigel M. Hooper
Frontiers in Cell and Developmental Biology
Open Access
Published: Aug 2014
19 citations
19 citations
3857 days before retraction
Advances in Therapeutics for Neurodegenerative Tauopathies: Moving toward the Specific Targeting of the Most Toxic Tau Species
Julia E. Gerson, Diana L. Castillo‐Carranza, Rakez Kayed
ACS Chemical Neuroscience
Published: Jul 2014
68 citations
68 citations
3878 days before retraction
Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics
William F. Goure, Grant A. Krafft, Jasna Jerecı̀ć et al. (4 authors)
Alzheimer s Research & Therapy
Open Access
Published: Jul 2014
170 citations
170 citations
3899 days before retraction
Role of PrPC Expression in Tau Protein Levels and Phosphorylation in Alzheimer’s Disease Evolution
Cristina Vergara, Lara Ordóñez‐Gutiérrez, Francisco Wandosell et al. (6 authors)
Molecular Neurobiology
Open Access
Published: Jun 2014
39 citations
39 citations
3913 days before retraction
Di-Tyrosine Cross-Link Decreases the Collisional Cross-Section of Aβ Peptide Dimers and Trimers in the Gas Phase: An Ion Mobility Study
Ewa Sitkiewicz, Jacek Olędzki, Jarosław Poznański et al. (4 authors)
PLoS ONE
Open Access
Published: Jun 2014
26 citations
26 citations
3919 days before retraction
PrPC signalling in neurons: From basics to clinical challenges
Théo Z. Hirsch, Julia Hernandez-Rapp, Severine Martin‐Lannerée et al. (5 authors)
Biochimie
Open Access
Published: Jun 2014
30 citations
30 citations
3920 days before retraction
Genetic Modulation of Soluble A Rescues Cognitive and Synaptic Impairment in a Mouse Model of Alzheimer's Disease
Stephanie Fowler, Angie C.A. Chiang, Ricky R. Savjani et al. (9 authors)
Journal of Neuroscience
Open Access
Published: Jun 2014
79 citations
79 citations
3934 days before retraction
Premature lethality, hyperactivity, and aberrant phosphorylation in transgenic mice expressing a constitutively active form of Fyn
Di Xia, Jà ⁄ rgen Götz
Frontiers in Molecular Neuroscience
Open Access
Published: May 2014
26 citations
26 citations
3956 days before retraction
A PrPC-caveolin-Lyn complex negatively controls neuronal GSK3β and serotonin 1B receptor
Julia Hernandez-Rapp, Severine Martin‐Lannerée, Théo Z. Hirsch et al. (9 authors)
Scientific Reports
Open Access
Published: May 2014
29 citations
29 citations
3961 days before retraction
The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease
Tara L. Spires‐Jones, Bradley T. Hyman
Neuron
Open Access
Published: May 2014
1047 citations
1047 citations
3968 days before retraction
Antioxidant and Metal Chelation-Based Therapies in the Treatment of Prion Disease
Marcus W. Brazier, Anthony G. Wedd, Steven Collins
Antioxidants
Open Access
Published: Apr 2014
13 citations
13 citations
3978 days before retraction
Translation of the Prion Protein mRNA Is Robust in Astrocytes but Does Not Amplify during Reactive Astrocytosis in the Mouse Brain
Walker S. Jackson, Clemens Krost, Andrew W. Borkowski et al. (4 authors)
PLoS ONE
Open Access
Published: Apr 2014
12 citations
12 citations
3978 days before retraction
Involvement of ‘stress–response’ kinase pathways in Alzheimer's disease progression
Georges Mairet‐Coello, Franck Polleux
Current Opinion in Neurobiology
Open Access
Published: Apr 2014
13 citations
13 citations
3994 days before retraction
Tau acts as a mediator for <scp>A</scp>lzheimer's disease‐related synaptic deficits
Dezhi Liao, Eric C. Miller, Peter J. Teravskis
European Journal of Neuroscience
Open Access
Published: Apr 2014
47 citations
47 citations
3998 days before retraction
Biochemical Distribution of Tau Protein in Synaptosomal Fraction of Transgenic Mice Expressing Human P301L Tau
Naruhiko Sahara, Miyuki Murayama, Makoto Higuchi et al. (5 authors)
Frontiers in Neurology
Open Access
Published: Mar 2014
38 citations
38 citations
4019 days before retraction
Loss of Prion Protein Leads to Age-Dependent Behavioral Abnormalities and Changes in Cytoskeletal Protein Expression
Matthias Schmitz, Catharina Marlies Greis, Philipp Ottis et al. (13 authors)
Molecular Neurobiology
Published: Mar 2014
40 citations
40 citations
4024 days before retraction
mGlu5 receptors and cellular prion protein mediate amyloid-β-facilitated synaptic long-term depression in vivo
Neng‐Wei Hu, Andrew J. Nicoll, Dainan Zhang et al. (10 authors)
Nature Communications
Open Access
Published: Mar 2014
169 citations
169 citations
4026 days before retraction
Prions and Prion-Like Pathogens in Neurodegenerative Disorders
Caterina Peggion, Maria Catia Sorgato, Alessandro Bertoli
Pathogens
Open Access
Published: Feb 2014
17 citations
17 citations
4040 days before retraction
Hyperphosphorylated Tau is Elevated in Alzheimer's Disease with Psychosis
Patrick S. Murray, Caitlin M. Kirkwood, Megan C. Gray et al. (10 authors)
Journal of Alzheimer s Disease
Open Access
Published: Feb 2014
61 citations
61 citations
4044 days before retraction
High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer’s disease
Frank Dohler, Diego Sepúlveda‐Falla, Susanne Krasemann et al. (9 authors)
Brain
Published: Feb 2014
104 citations
104 citations
4048 days before retraction
Reciprocal disruption of neuronal signaling and Aβ production mediated by extrasynaptic NMDA receptors: a downward spiral
Travis Rush, Alain Buisson
Cell and Tissue Research
Published: Feb 2014
41 citations
41 citations
4054 days before retraction
Des maladies à prions à la maladie d’Alzheimer
Mathéa Pietri, Aurélie Alleaume-Butaux, Jean‐Marie Launay et al. (5 authors)
médecine/sciences
Open Access
Published: Feb 2014
4057 days before retraction
Mapping It out: A Novel Signaling Pathway Linking Aβ-PrP&lt;sup&gt;c&lt;/sup&gt;-Fyn Complex to Cognitive Impairment in Alzheimer’s Disease
Yiling Wang, Lei Xue
Advances in Alzheimer s Disease
Open Access
Published: Jan 2014
4088 days before retraction
New light on prions: putative role of co-operation of PrPc and Aβ proteins in cognition
Adrian Andrzej Chrobak, Dariusz Adamek
Folia Neuropathologica
Open Access
Published: Jan 2014
5 citations
5 citations
4088 days before retraction
Fyn kinase inhibition as a novel therapy for Alzheimer’s disease
Haakon B. Nygaard, Christopher H. van Dyck, Stephen M. Strittmatter
Alzheimer s Research & Therapy
Open Access
Published: Jan 2014
188 citations
188 citations
4088 days before retraction
Selective vulnerability to neurodegenerative disease: the curious case of Prion Protein
Walker S. Jackson
Disease Models & Mechanisms
Open Access
Published: Jan 2014
96 citations
96 citations
4088 days before retraction
Hijacking PrPc-dependent signal transduction: when prions impair Aβ clearance
Julia Hernandez-Rapp, Severine Martin‐Lannerée, Théo Z. Hirsch et al. (5 authors)
Frontiers in Aging Neuroscience
Open Access
Published: Jan 2014
20 citations
20 citations
4088 days before retraction
Proteostasis and Secondary Proteinopathy in Alzheimer?s Disease
David R. Borchelt Guilian Xu, Lucia Notterpek Jada Lewis
Journal of Alzheimer’s Disease & Parkinsonism
Open Access
Published: Jan 2014
9 citations
9 citations
4088 days before retraction
The dendritic hypothesis for Alzheimer's disease pathophysiology
J. Nicholas Cochran, Alicia M. Hall, Erik D. Roberson
Brain Research Bulletin
Open Access
Published: Dec 2013
111 citations
111 citations
4108 days before retraction
Impact of the Cellular Prion Protein on Amyloid-β and 3PO-Tau Processing
Matthias Schmitz, Katharina Wulf, Sandra C. Signore et al. (9 authors)
Journal of Alzheimer s Disease
Open Access
Published: Nov 2013
26 citations
26 citations
4125 days before retraction
Quick Stats
Total Citations:
273
Years Since Retraction:
<1 year
Open Access:
Yes
Last Checked:
Jul 23, 2025